SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo raises enGene Therapeutics price target to $6 from $2

Valid market news retained in the public archive without immediate LiveCast distribution.

ENGN

Story updates

11:19:45 AM UTC
SquawkNews
ENGENE THERAPEUTICS INC.: WELLS FARGO RAISES TO OVERWEIGHT FROM EQUAL WEIGHT

Related stories